Serotonin–dopamine interaction: electrophysiological evidence

G Di Giovanni, V Di Matteo, M Pierucci… - Progress in brain …, 2008 - Elsevier
In this review, the most relevant data regarding serotonin (5-hydroxytryptamine, 5-
HT)/dopamine (DA) interaction in the brain, as studied by both in vivo and in vitro …

Pharmacology and Therapeutic Potential of the 5-HT7 Receptor

KM Blattner, DJ Canney, DA Pippin… - ACS Chemical …, 2018 - ACS Publications
It is well-documented that serotonin (5-HT) exerts its pharmacological effects through a
series of 5-HT receptors. The most recently identified member of this family, 5-HT7, was first …

[HTML][HTML] The 5-HT7 receptor as a potential target for treating drug and alcohol abuse

SR Hauser, PB Hedlund, AJ Roberts, Y Sari… - Frontiers in …, 2015 - frontiersin.org
Alcohol and drug abuse take a large toll on society and affected individuals. However, very
few effective treatments are currently available to treat alcohol and drug addiction. Basic and …

The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways

L Speranza, A Chambery, M Di Domenico… - …, 2013 - Elsevier
Serotonergic neurotransmission is mediated by at least 14 subtypes of 5-HT receptors.
Among these, the CNS serotonin receptor 7 (5-HTR7) is involved in diverse physiological …

[PDF][PDF] Influence of serotonin 5-HT7 receptor blockade on the behavioral and neurochemical effects of imipramine in rats.

A Wesolowska, M Kowalska - Pharmacological Reports, 2008 - if-pan.krakow.pl
The aim of the present study was to examine the effect of the selective 5-HT7 receptor
antagonist (2R)-1-[(3-hydroxyphenyl) sulfonyl]-2-[2-(4-methyl-1-piperidinyl) ethyl] pyrrolidine …

Methylphenidate to adolescent rats drives enduring changes of accumbal Htr7 expression: implications for impulsive behavior and neuronal morphology

D Leo, W Adriani, C Cavaliere, G Cirillo… - Genes, Brain and …, 2009 - Wiley Online Library
Methylphenidate (MPH) administration to adolescent rodents produces persistent region‐
specific changes in brain reward circuits and alterations of reward‐based behavior. We …

Effects of SB-269970, a 5-HT7 receptor antagonist, in mouse models predictive of antipsychotic-like activity

R Galici, JD Boggs, KL Miller… - Behavioural …, 2008 - journals.lww.com
HT 7 receptors have been linked to a number of psychiatric disorders including anxiety and
depression. The localization of 5-HT 7 receptors in the thalamus, a key sensory processing …

Therapeutic potential of 5-HT7 receptors in mood disorders

O Mnie-Filali, L Lambas-Señas, H Scarna… - Current drug …, 2009 - ingentaconnect.com
Serotonin (5-HT) exerts its diverse physiological and pharmacological effects through the
activation of multiple receptor subtypes. One of the newest members of this family is the 5 …

Serotonergic imaging in Parkinson's disease

ER de Natale, H Wilson, M Politis - Progress in Brain Research, 2021 - Elsevier
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive
degeneration of monoaminergic central pathways such as the serotonergic. The …

Update on the development of lurasidone as a treatment for patients with acute schizophrenia

N Yasui-Furukori - Drug design, development and therapy, 2012 - Taylor & Francis
Lurasidone is a novel benzisothiazole antipsychotic drug for the treatment of schizophrenia.
Of the antipsychotic drugs, lurasidone has the highest affinity for the 5-hydroxytryptamine (5 …